Global Skin and Subcutaneous Tissue Diseases Mortality by Country

The global mortality rates for skin and subcutaneous tissue diseases exhibit significant regional disparities. Argentina, Brazil, and South Africa register the highest rates, while countries like Switzerland, Denmark, and Estonia boast the lowest. Year-on-year variations show substantial increases in Portugal, Colombia, and Finland, indicating potential emerging challenges. Declines are notable in Latvia, South Korea, and Switzerland, reflecting successful interventions or healthcare improvements. The last five years' CAGR points to an average rise in mortality rates, primarily driven by Latin American countries.

Future trends to watch include technological advancements in healthcare, potential increases in disease awareness and preventive measures, and the impact of economic and environmental factors on health outcomes in different regions. Monitoring how healthcare policies adapt to these challenges will be crucial in addressing regional disparities in mortality rates.

Top countries in Skin and Subcutaneous Tissue Diseases Mortality by Country

# 10 Countries Units (Male Deaths) Per Hundred Thousand Men, Standardised Rates Last Year YoY 5-years CAGR
1 1 Argentina 10.2 2023 +6.25% +2.53% View data
2 2 Brazil 7.9 2023 +3.95% +6.75% View data
3 3 South Africa 6.9 2023 0% -0.29% View data
4 4 Mexico 6.7 2023 +8.06% +1.89% View data
5 5 Colombia 6.6 2023 0% +8.95% View data
6 6 Israel 6.2 2023 +3.33% -0.94% View data
7 7 Chile 5.6 2023 +1.82% -3.81% View data
8 8 Peru 5.4 2023 +10.2% +1.55% View data
9 9 Costa Rica 4.6 2023 +4.55% -2.04% View data
10 10 Slovakia 4.4 2023 0% +1.92% View data

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease